X

Due to the lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

Updates regarding government operating status and resumption of normal operations can be found at http://www.usa.gov.
NOT-FD-14-006: Notice of Correction to Funds Available and Anticipated Number of Awards for RFA-FD-14-007 "Dissolution Methods for Microsphere and Implant Drug Products (U01)"
Notice of Correction to Funds Available and Anticipated Number of Awards for RFA-FD-14-007 "Dissolution Methods for Microsphere and Implant Drug Products (U01)"

Notice Number: NOT-FD-14-006

Key Dates
Release Date: April 9, 2014

Related Announcements
RFA-FD-14-007

Issued by
U.S. Food and Drug Administration

Purpose

The purpose of this Notice is to correct the Funds Available and Anticipated Number of Awards for RFA-FD-14-007

Now Reads:


Funds Available and Anticipated Number of Awards

The FDA and partner components intend to commit an estimated total of $500,000 to fund 2 awards.


Should Read:


Funds Available and Anticipated Number of Awards

The FDA and partner components intend to commit an estimated total of $500,000 per award.  Up to 2 awards may be funded.


Inquiries

Please direct all inquiries to:

Gladys Melendez (Bohler)
Food and Drug Administration (FDA)
Telephone: 301-515-0642
Email: gladys.bohler@fda.hhs.gov